In this episode, DLA Piper partner Danny Tobey is joined by Aviva Wein, Assistant General Counsel at Johnson & Johnson, to discuss how medical device and pharmaceutical companies are future-proofing their innovations in artificial intelligence as new regulations and risks arise.
| less than a minute read
AI risk assessments: Future-proofing your innovation when rules can change mid-game - At the Intersection of Science and Law Podcast Series
Get in touch
Get in touch
Get in touch
Get in touch
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-03-19-17-30-27-593-65f9cbb3bf22b75d160b136f.jpg)
Welcome to ‘What every Life Sciences lawyer needs (Commercial Contracts)’, a series in which DLA Piper’s Life Sciences Commercial...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-04-22-08-46-05-640-662623cd0532c9880e85e938.jpg)
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-04-18-09-16-42-370-6620e4fa7330266071d4ac1d.jpg)
/Passle/596df0e43d947619ec025f26/MediaLibrary/Document/2024-04-15-09-40-05-618-LS_marzec_2024_EN_thumbnail_1.png)
/Passle/596df0e43d947619ec025f26/MediaLibrary/Video/Transcoded/2024-04-10-12-51-54-366-CST0671_Inspirational_Women_in_Life_Sciences_Lisa_L/thumbnails/2024-04-10-12-51-54-366-CST0671_Inspirational_Women_in_Life_Sciences_Lisa_L_HLS_Video_2M_1080P_00002.png)
